OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration

PHASE2CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

March 31, 2006

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Geographic AtrophyAge-Related Macular DegenerationAMD
Interventions
DRUG

OT-551 antioxidant eye drop

0.45% concentration of OT-551 eye drops were given three times a day on participants with geographic atrophy area for up to three years. Participants had one eye randomized to receive the eye drop and the fellow eye was observed.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

National Eye Institute (NEI)

NIH

collaborator

Othera Pharmaceuticals

INDUSTRY

lead

National Institutes of Health Clinical Center (CC)

NIH